Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL-1 polymorphisms modulates functional recovery following rehabilitation in multiple sclerosis.

Frontiers in immunology·2026
Same author

Irisin hampers β-amyloid-induced microglial inflammation <i>via</i> the miR-451a/TLR4/NLRP3 axis.

Frontiers in immunology·2026
Same author

Evaluating long non-coding RNA signatures as biomarkers for inflammatory pathway regulation and rehabilitative outcomes in Parkinson's disease: toward a precision medicine approach.

Frontiers in immunology·2026
Same author

Quality of life of patients with Kaposi Sarcoma: a cross-sectional study.

Italian journal of dermatology and venereology·2026
Same author

Analysis of AQP4 SNPs and Their Association With REM Sleep Behavior Disorder and Hallucinations in Parkinson's Disease.

Molecular neurobiology·2025
Same author

Special Issue: "New Challenges of Parkinson's Disease".

International journal of molecular sciences·2025

Related Experiment Video

Updated: May 23, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

Activating KIR/HLA complexes in classic Kaposi's Sarcoma.

Franca R Guerini1, Roberta Mancuso, Simone Agostini

  • 1Don C, Gnocchi Foundation ONLUS, P, le Morandi 6, 20121 Milan, Italy. mario.clerici@unimi.it.

Infectious Agents and Cancer
|April 4, 2012
PubMed
Summary

Certain activating KIR/HLA genotypes are more common in classic Kaposi's Sarcoma (cKS) cases. This suggests a role for Natural Killer (NK) cell activation in cKS development, even without direct KSHV infection association.

More Related Videos

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

Related Experiment Videos

Last Updated: May 23, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

Area of Science:

  • Immunogenetics
  • Oncology
  • Virology

Background:

  • Classic Kaposi's Sarcoma (cKS) is a rare vascular tumor linked to Human Herpesvirus 8 (KSHV) infection.
  • Not all KSHV-infected individuals develop cKS, indicating other factors influence disease development.

Purpose of the Study:

  • To determine if specific KIR/HLA receptor/ligand genotypes are associated with cKS development in KSHV-infected individuals.
  • To compare genotype frequencies between KSHV-infected individuals with and without cKS, and with KSHV-seronegative controls.

Main Methods:

  • Molecular genotyping was used to analyze KIR/HLA genotypes.
  • Study included 50 KSHV-infected individuals (with or without cKS) and 33 KSHV-seronegative controls.

Main Results:

  • No individual KIR, HLA, or receptor-ligand combinations were associated with KSHV infection itself.
  • Activating KIR and KIR/HLA genotypes, including KIR3DS1, KIR2DS1, and KIR2DS1/HLA-C2, were significantly more frequent in cKS cases.

Conclusions:

  • Specific activating KIR/HLA genotypes may contribute to the pathogenesis of Kaposi's Sarcoma.
  • NK cell activation via KIR-HLA interactions could play a role in cKS development, independent of direct KSHV association.